Pneumococcal Vaccines Market
Keen Attention on the Development of Affordable and Economical Vaccines Strengthen the Reach of Immunization Awareness Campaigns Across Developing Economics. Here’s More with FMI.
Pneumococcal Vaccines Market by Product Type, Distribution Channel & Region - Forecast 2023 - 2033
A Summary of the Pneumococcal Vaccines Market Development 2023 - 2033
The global pneumococcal vaccines market is projected to have an average-paced CAGR of 4.1% during the forecast period. The current valuation of the market is US$ 8.9 Bn in 2023. The market value of the pneumococcal vaccines market is anticipated to surpass a market valuation of US$ 13.3 Bn by 2033. A historical market valuation of US$ 8.5 Bn has been recorded by the analysts of Future Market Insights for the concerned market during the base year.
Growth is supported by:
- Surging awareness amongst the global population in regard to immunization programs for pneumonia is likely to aid the market growth.
- Increase in government support to educate people about being vaccinated against the occurrence of pneumonia is estimated to reshape the market landscape through 2033.
- Rise in the prevalence of pneumococcal contaminations within the growing population is identified as a key cause behind the industry expansion.
- Introduction of novel vaccines for the prevention of pneumococcal diseases is the major driving factor of the pneumococcal vaccines industry.
- Rising prevalence of bloodstream infection, bacteremic pneumonia, meningitis, middle ear infection, and bacteremia is a key growth propellant of the market.
|
Report Attribute |
Details |
|
Pneumococcal Vaccines Market Value (2023) |
US$ 8.9 Bn |
|
Pneumococcal Vaccines Market Anticipated Value (2033) |
US$ 13.3 Bn |
|
Pneumococcal Vaccines Projected Growth Rate (2023-2033) |
4.1% |
Let us know your requirement to get
100% FREE customization
Stretched Timelines to Manufacture Pneumococcal Vaccines Limits Market Growth
Although the market is estimated to have favorable growth through the forecast period, it is identified that certain factors prevailing in the market are likely to curb the demand for pneumococcal vaccines in the forthcoming years.
It is witnessed that the manufacturing or production process of pneumococcal vaccines requires a longer timeline, which acts as a key restraining element in the market expansion. Additionally, there is a very high cost associated with the development of pneumococcal vaccines. Therefore, it is expected that the aforementioned factors are likely to hinder the propulsion of industry through the forecast period.
Manufacture of Protein-based Vaccines Narrows Immunization Gaps Amidst People Across Developing Economies
The industry players are diversifying their product portfolios with the launch of protein-based vaccines. The introduction of protein-based vaccines is creating several growth opportunities in the market to further expand and upscale the prominence of pneumococcal vaccines.
Moreover, protein-based vaccines have inexpensive production procedures that further aid the market’s prominence. Additionally, these products have logistical and protocol advantages, along with the inclusion of stability at a broad range of temperatures.
These vaccines are identified to narrow the immunization gaps that prevail among the middle-class and abundant populace across developing economies. Therefore, it is estimated that the pneumococcal vaccines market is likely to accrue significant shares through the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystPCV in Infant Routine Immunization in 2023 Excel Against the Historical Market Scenario
It is identified that the pneumococcal vaccines market is witnessing an unprecedented surge in the recent few years. There has been an approximate rise of US$ 0.4 Bn from the base year to the current. This growth in market valuation can be highly attributed to the rising number of young children under 2 to 5 years possessing a high risk of pneumococcal diseases.
The rising geriatric population has also made a a significant contribution to the industry growth of pneumococcal vaccines. Severe complications and contagiousness of diseases in old adults have fostered the growth of the pneumococcal vaccines market during the period 2018-2022.
The market advanced at a moderate pace of 3.2% CAGR and accounted for a market value of US$ 8.5 Bn in the base year. It is identified that the rise in the number of diabetes patients, smokers, heavy drinkers, and individuals having chronic health conditions, who are vulnerable to ailments and infections owing to their weak immune systems is estimated to further fuel demand through the foreseen years.
Additionally, a key factor making a significant contribution to the market growth is the introduction of the Pneumococcal Conjugate Vaccine (PCV) by government agencies across emerging countries in infant routine immunization. This factor is expected to further trail growth through the projection period.
|
Historical CAGR (2018-2022) |
Forecast CAGR (2023-2033) |
|
3.2% |
4.1% |
|
Market Value in 2022 |
Market Value in 2023 |
|
US$ 8.5 Bn |
US$ 8.9 Mn |
Comparative Analysis of Adjacent Markets
Pneumococcal Vaccines Market:
|
Differentiating Aspects |
Pneumococcal Vaccines Market |
|
CAGR |
4.1% |
|
Market Valuation in 2023 |
US$ 8.9 Bn |
|
Projected Market Value in 2033 |
US$ 13.3 Bn |
|
Drivers |
|
Cancer Vaccines Market:
|
Differentiating Aspects |
Cancer Vaccines Market |
|
CAGR |
14.7% |
|
Market Valuation in 2023 |
US$ 8.40 Bn |
|
Projected Market Value in 2033 |
US$ 33.09 Bn |
|
Drivers |
|
Global Vaccine Market:
|
Differentiating Aspects |
Global Vaccine Market |
|
CAGR |
10.2% |
|
Market Valuation in 2023 |
US$ 50.21 Bn |
|
Projected Market Value in 2033 |
US$ 85.71 Bn |
|
Drivers |
|
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-wise Insights
Dominant Market Segments Expand as a Result of the Introduction Of New Products and the Rise In Health Concerns.
Prevenar-13 – By Product Type
It is identified that the Prevenar-13 segment by product type category is likely to trail at a significant rate through the forecast period. In the base year, this segment was advancing forward at a CAGR of 3.2% and is likely to hold dominant shares in the pneumococcal vaccines market through 2033.
This segment is projected to account for a revenue share of US$ 9,500 Mn in 2023. The growing prominence of Prevenar 13 can be attributed to the inclusion of thirteen pneumococcus and serotypes. The hospital sector is giving this vaccine to patients due to the presence of serotypes 6A and 19A.
The Centers for Disease Control and Prevention (CDC) has also made recommendations for Prevenar-13 for adults, who are above the age of 65 years. Therefore, this segment is likely to accrue significant shares of the market through 2033.
Public Authorities – By Distribution Channel
After an in-depth analysis of the market, it is witnessed that the public authorities segment by distribution channel category is likely to hold dominant shares in the pneumococcal vaccines market. In 2022, this segment trailed at a CAGR of 6.8% and is likely to move forward at a notable pace, registering a CAGR of 5% during the period 2023-2033.
Public health agencies and community clinics are accounting for the largest market share owing to the large number of vaccine purchases made by organizations such as GAVI, WHO, UNICEF, and others. These organizations make bulk purchases of pneumonia vaccines and distribute them across diver geographies for social causes.
The hospital segment is also estimated to have grown at a significant rate and is projected to surpass a market valuation of US$ 12,400 Mn by the end of 2023.
Country-wise Insights
Regional Market Shares in the Pneumococcal Vaccines Market
| Regions |
North America |
| Countries |
United States |
| CAGR (2023-2033) |
1.8% |
| Regions |
Europe |
| Countries |
United Kingdom , Germany |
| CAGR (2023-2033) |
2.5% , 2.9% |
| Regions |
Asia Pacific |
| Countries |
China , India |
| CAGR (2023-2033) |
9.0% , 9.2% |
Introduction of Awareness Programs Across Diverse Countries Promote Industry Growth of Pneumococcal Vaccines
| Country |
United States |
| Statistics |
The U.S. is estimated to hold the highest share of the pneumococcal vaccines market through the projection period. The pneumococcal vaccines industry in the U.S. is advancing at a CAGR of 1.8%. the market is estimated to surpass a valuation of US$ 4.9 Bn by the end of 2033. Approximate Growth in Market Value: US$ 825.6 Mn |
| Growth Propellants |
A well-established healthcare infrastructure across the North American region serving a large number of patients is estimated to foster the growth of the pneumococcal market in the upcoming years. It is identified that the 5-7% mortality rate in the U.S. is due to pneumococcal diseases. The rapid growth in the geriatric population is also a key factor fueling the market expansion of pneumococcal vaccines. |
| Country |
Germany |
| Statistics |
Germany is likely to hold a significant share of the pneumococcal vaccines market in the European region. The pneumococcal vaccines industry in the U.K. is advancing at a CAGR of 2.9%. The market is estimated to surpass a valuation of US$ 191.9 Mn by the end of 2033. Approximate Growth in Market Value: US$ 47.2 Mn |
| Growth Propellants |
The high prevalence and invasion of pneumonia across the people of Europe which accounted for approximately 15.08% of 1,00,000 people is a key cause fueling the market size of pneumococcal vaccines in Germany. Furthermore, a growing number of research and development activities and clinical trials aided by government advances in the country is reshaping the industry landscape in 2023. |
| Country |
China |
| Statistics |
The pneumococcal vaccines market in China is estimated to move forward at a substantial rate, slating a CAGR of 9.0% through the forecast period. The market is estimated to surpass a valuation of US$ 2.9 Bn by the end of 2033. Approximate Growth in Market Value: US$ 1.7 Bn |
| Growth Propellants |
The medical healthcare sector across China is witnessing a rise in investment from government authorities. Medical institutes across China are heavily using pneumococcal vaccines for treating diseases like meningitis, blood-stream infection, and more. Therefore, it is estimated to emerge as one of the most significant and remunerative markets in the pneumococcal vaccine landscape. |
Start-up Ecosystem
Attempts of New Entrants Penetrate Remunerative Market Scopes
The new entrants in the pneumococcal vaccines market are leveraging advancements in technology to launch new products and gain a competitive advantage. These firms are continually investing in research and development activities to keep themselves in tandem with the changing consumer preferences and end-use industry demands. Efforts are being made to strengthen their foothold in the market and aid the further progression of the pneumococcal vaccines market.
Top 2 Start-ups to Watch For
Affinivax – This firm is a clinical-stage biopharmaceutical organization, who are having a next-generation technology platform for vaccines known as the multiple antigen presentation systems. This firm is likely to penetrate the market and be in tandem with the demand from the hospital sector through the forecast period.
GPN Vaccine – This is an Australian start-up firm that is offering vaccines for pneumonia. The startup sterilizes its proprietary, engineered, and avirulent strain ofS. pneumoniae with gamma-rays to produce Gamma-PNTM, a whole-cell vaccine. The vaccine induces broad-spectrum immunity against the antigens of the pneumococcus bacterium and is effective against different pathogenic pneumococcal strains.
Competitive Landscape
Key Industry Players Cede A Silver Lining to the Pneumonia Vaccines Market With Their Technology Innovations
The pneumococcal vaccines market is highly fragmented and the key manufacturers are deploying several organic and inorganic growth strategies to compete with the existing players in the market. The biggies are heavily investing in research and development activities to leverage advancements to the attributes of pneumococcal vaccines. They are making attempts for treating the chronic diseases prevailing amongst the geriatric population and others in an effective manner.
Activirosomes is developing vaccines for viral infections. The company is leveraging active virosome technology for the generation of non-replicating derivates of measles and some other comprehensive viruses. The virosome-based vaccines are carrying only the viral genes that are necessary for eliciting an immune response.
Recent Developments
- In September 2020, a Japanese pharmaceutical company, Shinogi, made an announcement to enter into a license agreement with Hanavax, a next-generation nasal vaccine manufacturer. The agreement was likely to assist the company in research and development activities, commercialization, manufacturing, and distribution of Streptococcus pneumonia vaccines developed by Hanavax.
- In December 2019, China-based biotechnology company, Walvax Biotechnology Co., Ltd. received approval from the regulatory body of China, the National Medical Products Administration for its pneumococcal-13 valent conjugate vaccine. This vaccine is also estimated to act as an alternative to Prevnar-13 for immunizing children in the age group of 6 months to 5 years.
- In January 2018, Pfizer, one of the global leaders in the pharmaceutical industry made an announcement to reduce the price of the PCV-13 4-dose vial vaccine from US$ 3.05 to US$ 2.95 per dosage in the Gavi-supported countries.
Some of the key players proliferating in the market are:
- Astellas Pharma Inc
- GlaxoSmithKline Plc
- Merck & Co. Inc
- Panacea Biotech Ltd
- Pfizer Inc
- Sanofi S.A
- Walvax Biotechnology Co. Ltd
- CSL Ltd
- Serum Institute of India Pvt. Ltd
- Talley Group Ltd
Key Segments in the Pneumococcal Vaccines Market
By Product Type:
- Pneumococcal Polysaccharide Vaccines
- Pneumococcal Conjugate Vaccines
By Distribution Channel:
- Pharmacies
- Community Clinics
- Public Health Agencies
- Others
By Region:
- North America
- Latin America
- Asia Pacific
- MEA
- Europe
Frequently Asked Questions
The growth outlook for the market is predicted to advance at a CAGR of 4.1% from 2023 to 2033.
The North American region is anticipated to lead the market during the forecast period.
The market valuation of the market stands at US$ 8.9 Bn in 2023.
The market is likely to hold a valuation of US$ 13.3 Bn by 2033.
The healthcare industry sector is the key driver in the market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2022
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product Type, 2017-2022
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product Type, 2023-2033
5.3.1. Synflorix
5.3.2. Prevenar-13
5.3.3. PCV 13 (Pipeline)
5.3.4. V114 (Merck)
5.3.5. PCV-20 (Pfizer)
5.3.6. PCV-10 (SII)
5.3.7. PPSV- 23
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023-2033
6. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Distribution Channels
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channels, 2017-2022
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channels, 2023-2033
6.3.1. Wholesaler (Pharmacy channel)
6.3.2. Specialized Companies
6.3.3. Public Authorities
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By Distribution Channels, 2017-2022
6.5. Absolute $ Opportunity Analysis By Distribution Channels, 2023-2033
7. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Sector
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Sector , 2017-2022
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Sector , 2023-2033
7.3.1. Public
7.3.2. Private
7.4. Y-o-Y Growth Trend Analysis By Sector , 2017-2022
7.5. Absolute $ Opportunity Analysis By Sector , 2023-2033
8. Global Market Analysis 2017-2022 and Forecast 2023-2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2022
8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2023-2033
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Rest of the World
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017-2022 and Forecast 2023-2033, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Distribution Channels
9.2.4. By Sector
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Distribution Channels
9.3.4. By Sector
9.4. Key Takeaways
10. Europe Market Analysis 2017-2022 and Forecast 2023-2033, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
10.2.1. By Country
10.2.1.1. U.K.
10.2.1.2. Germany
10.2.1.3. Spain
10.2.1.4. France
10.2.1.5. Italy
10.2.1.6. Belgium
10.2.1.7. Rest of Europe
10.2.2. By Product Type
10.2.3. By Distribution Channels
10.2.4. By Sector
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Distribution Channels
10.3.4. By Sector
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2017-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. India
11.2.1.4. Australia
11.2.1.5. New Zealand
11.2.1.6. Rest of Asia Pacific
11.2.2. By Product Type
11.2.3. By Distribution Channels
11.2.4. By Sector
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Distribution Channels
11.3.4. By Sector
11.4. Key Takeaways
12. Latin America Market Analysis 2017-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Product Type
12.2.3. By Distribution Channels
12.2.4. By Sector
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Distribution Channels
12.3.4. By Sector
12.4. Key Takeaways
13. Rest of the World Market Analysis 2017-2022 and Forecast 2023-2033, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2022
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
13.2.1. By Country
13.2.1.1. Rest of the World
13.2.2. By Product Type
13.2.3. By Distribution Channels
13.2.4. By Sector
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Distribution Channels
13.3.4. By Sector
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Product Type
14.1.2.2. By Distribution Channels
14.1.2.3. By Sector
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Product Type
14.2.2.2. By Distribution Channels
14.2.2.3. By Sector
14.3. U.K.
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Product Type
14.3.2.2. By Distribution Channels
14.3.2.3. By Sector
14.4. Germany
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Product Type
14.4.2.2. By Distribution Channels
14.4.2.3. By Sector
14.5. Spain
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Product Type
14.5.2.2. By Distribution Channels
14.5.2.3. By Sector
14.6. France
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Product Type
14.6.2.2. By Distribution Channels
14.6.2.3. By Sector
14.7. Italy
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Product Type
14.7.2.2. By Distribution Channels
14.7.2.3. By Sector
14.8. Belgium
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Product Type
14.8.2.2. By Distribution Channels
14.8.2.3. By Sector
14.9. China
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Product Type
14.9.2.2. By Distribution Channels
14.9.2.3. By Sector
14.10. Japan
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Product Type
14.10.2.2. By Distribution Channels
14.10.2.3. By Sector
14.11. India
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Product Type
14.11.2.2. By Distribution Channels
14.11.2.3. By Sector
14.12. Australia
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Product Type
14.12.2.2. By Distribution Channels
14.12.2.3. By Sector
14.13. New Zealand
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Product Type
14.13.2.2. By Distribution Channels
14.13.2.3. By Sector
14.14. Brazil
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Product Type
14.14.2.2. By Distribution Channels
14.14.2.3. By Sector
14.15. Mexico
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Product Type
14.15.2.2. By Distribution Channels
14.15.2.3. By Sector
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Type
15.3.3. By Distribution Channels
15.3.4. By Sector
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Glaxosmithkline plc.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.2. LG Chem Ltd.
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.3. Merck & Co., Inc.
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.4. Panacea Biotec Limited
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.5. Pfizer Inc.
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.6. Pnuvax Incorporated
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.7. Serum Institute of India Pvt. Ltd.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.8. Shenzhen Kangtai Biological Products Co., Ltd.
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.9. SK Bioscience
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.10. Walvax Biotechnology Co., Ltd.
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2033
Table 2: Global Market Value (US$ Mn) Forecast by Product Type, 2017-2033
Table 3: Global Market Value (US$ Mn) Forecast by Distribution Channels, 2017-2033
Table 4: Global Market Value (US$ Mn) Forecast by Sector , 2017-2033
Table 5: North America Market Value (US$ Mn) Forecast by Country, 2017-2033
Table 6: North America Market Value (US$ Mn) Forecast by Product Type, 2017-2033
Table 7: North America Market Value (US$ Mn) Forecast by Distribution Channels, 2017-2033
Table 8: North America Market Value (US$ Mn) Forecast by Sector , 2017-2033
Table 9: Europe Market Value (US$ Mn) Forecast by Country, 2017-2033
Table 10: Europe Market Value (US$ Mn) Forecast by Product Type, 2017-2033
Table 11: Europe Market Value (US$ Mn) Forecast by Distribution Channels, 2017-2033
Table 12: Europe Market Value (US$ Mn) Forecast by Sector , 2017-2033
Table 13: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2033
Table 14: Asia Pacific Market Value (US$ Mn) Forecast by Product Type, 2017-2033
Table 15: Asia Pacific Market Value (US$ Mn) Forecast by Distribution Channels, 2017-2033
Table 16: Asia Pacific Market Value (US$ Mn) Forecast by Sector , 2017-2033
Table 17: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2033
Table 18: Latin America Market Value (US$ Mn) Forecast by Product Type, 2017-2033
Table 19: Latin America Market Value (US$ Mn) Forecast by Distribution Channels, 2017-2033
Table 20: Latin America Market Value (US$ Mn) Forecast by Sector , 2017-2033
Table 21: Rest of the World Market Value (US$ Mn) Forecast by Country, 2017-2033
Table 22: Rest of the World Market Value (US$ Mn) Forecast by Product Type, 2017-2033
Table 23: Rest of the World Market Value (US$ Mn) Forecast by Distribution Channels, 2017-2033
Table 24: Rest of the World Market Value (US$ Mn) Forecast by Sector , 2017-2033
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) by Product Type, 2023-2033
Figure 2: Global Market Value (US$ Mn) by Distribution Channels, 2023-2033
Figure 3: Global Market Value (US$ Mn) by Sector , 2023-2033
Figure 4: Global Market Value (US$ Mn) by Region, 2023-2033
Figure 5: Global Market Value (US$ Mn) Analysis by Region, 2017-2033
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023-2033
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023-2033
Figure 8: Global Market Value (US$ Mn) Analysis by Product Type, 2017-2033
Figure 9: Global Market Value Share (%) and BPS Analysis by Product Type, 2023-2033
Figure 10: Global Market Y-o-Y Growth (%) Projections by Product Type, 2023-2033
Figure 11: Global Market Value (US$ Mn) Analysis by Distribution Channels, 2017-2033
Figure 12: Global Market Value Share (%) and BPS Analysis by Distribution Channels, 2023-2033
Figure 13: Global Market Y-o-Y Growth (%) Projections by Distribution Channels, 2023-2033
Figure 14: Global Market Value (US$ Mn) Analysis by Sector , 2017-2033
Figure 15: Global Market Value Share (%) and BPS Analysis by Sector , 2023-2033
Figure 16: Global Market Y-o-Y Growth (%) Projections by Sector , 2023-2033
Figure 17: Global Market Attractiveness by Product Type, 2023-2033
Figure 18: Global Market Attractiveness by Distribution Channels, 2023-2033
Figure 19: Global Market Attractiveness by Sector , 2023-2033
Figure 20: Global Market Attractiveness by Region, 2023-2033
Figure 21: North America Market Value (US$ Mn) by Product Type, 2023-2033
Figure 22: North America Market Value (US$ Mn) by Distribution Channels, 2023-2033
Figure 23: North America Market Value (US$ Mn) by Sector , 2023-2033
Figure 24: North America Market Value (US$ Mn) by Country, 2023-2033
Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2017-2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 28: North America Market Value (US$ Mn) Analysis by Product Type, 2017-2033
Figure 29: North America Market Value Share (%) and BPS Analysis by Product Type, 2023-2033
Figure 30: North America Market Y-o-Y Growth (%) Projections by Product Type, 2023-2033
Figure 31: North America Market Value (US$ Mn) Analysis by Distribution Channels, 2017-2033
Figure 32: North America Market Value Share (%) and BPS Analysis by Distribution Channels, 2023-2033
Figure 33: North America Market Y-o-Y Growth (%) Projections by Distribution Channels, 2023-2033
Figure 34: North America Market Value (US$ Mn) Analysis by Sector , 2017-2033
Figure 35: North America Market Value Share (%) and BPS Analysis by Sector , 2023-2033
Figure 36: North America Market Y-o-Y Growth (%) Projections by Sector , 2023-2033
Figure 37: North America Market Attractiveness by Product Type, 2023-2033
Figure 38: North America Market Attractiveness by Distribution Channels, 2023-2033
Figure 39: North America Market Attractiveness by Sector , 2023-2033
Figure 40: North America Market Attractiveness by Country, 2023-2033
Figure 41: Europe Market Value (US$ Mn) by Product Type, 2023-2033
Figure 42: Europe Market Value (US$ Mn) by Distribution Channels, 2023-2033
Figure 43: Europe Market Value (US$ Mn) by Sector , 2023-2033
Figure 44: Europe Market Value (US$ Mn) by Country, 2023-2033
Figure 45: Europe Market Value (US$ Mn) Analysis by Country, 2017-2033
Figure 46: Europe Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 47: Europe Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 48: Europe Market Value (US$ Mn) Analysis by Product Type, 2017-2033
Figure 49: Europe Market Value Share (%) and BPS Analysis by Product Type, 2023-2033
Figure 50: Europe Market Y-o-Y Growth (%) Projections by Product Type, 2023-2033
Figure 51: Europe Market Value (US$ Mn) Analysis by Distribution Channels, 2017-2033
Figure 52: Europe Market Value Share (%) and BPS Analysis by Distribution Channels, 2023-2033
Figure 53: Europe Market Y-o-Y Growth (%) Projections by Distribution Channels, 2023-2033
Figure 54: Europe Market Value (US$ Mn) Analysis by Sector , 2017-2033
Figure 55: Europe Market Value Share (%) and BPS Analysis by Sector , 2023-2033
Figure 56: Europe Market Y-o-Y Growth (%) Projections by Sector , 2023-2033
Figure 57: Europe Market Attractiveness by Product Type, 2023-2033
Figure 58: Europe Market Attractiveness by Distribution Channels, 2023-2033
Figure 59: Europe Market Attractiveness by Sector , 2023-2033
Figure 60: Europe Market Attractiveness by Country, 2023-2033
Figure 61: Asia Pacific Market Value (US$ Mn) by Product Type, 2023-2033
Figure 62: Asia Pacific Market Value (US$ Mn) by Distribution Channels, 2023-2033
Figure 63: Asia Pacific Market Value (US$ Mn) by Sector , 2023-2033
Figure 64: Asia Pacific Market Value (US$ Mn) by Country, 2023-2033
Figure 65: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2033
Figure 66: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 67: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 68: Asia Pacific Market Value (US$ Mn) Analysis by Product Type, 2017-2033
Figure 69: Asia Pacific Market Value Share (%) and BPS Analysis by Product Type, 2023-2033
Figure 70: Asia Pacific Market Y-o-Y Growth (%) Projections by Product Type, 2023-2033
Figure 71: Asia Pacific Market Value (US$ Mn) Analysis by Distribution Channels, 2017-2033
Figure 72: Asia Pacific Market Value Share (%) and BPS Analysis by Distribution Channels, 2023-2033
Figure 73: Asia Pacific Market Y-o-Y Growth (%) Projections by Distribution Channels, 2023-2033
Figure 74: Asia Pacific Market Value (US$ Mn) Analysis by Sector , 2017-2033
Figure 75: Asia Pacific Market Value Share (%) and BPS Analysis by Sector , 2023-2033
Figure 76: Asia Pacific Market Y-o-Y Growth (%) Projections by Sector , 2023-2033
Figure 77: Asia Pacific Market Attractiveness by Product Type, 2023-2033
Figure 78: Asia Pacific Market Attractiveness by Distribution Channels, 2023-2033
Figure 79: Asia Pacific Market Attractiveness by Sector , 2023-2033
Figure 80: Asia Pacific Market Attractiveness by Country, 2023-2033
Figure 81: Latin America Market Value (US$ Mn) by Product Type, 2023-2033
Figure 82: Latin America Market Value (US$ Mn) by Distribution Channels, 2023-2033
Figure 83: Latin America Market Value (US$ Mn) by Sector , 2023-2033
Figure 84: Latin America Market Value (US$ Mn) by Country, 2023-2033
Figure 85: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2033
Figure 86: Latin America Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 87: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 88: Latin America Market Value (US$ Mn) Analysis by Product Type, 2017-2033
Figure 89: Latin America Market Value Share (%) and BPS Analysis by Product Type, 2023-2033
Figure 90: Latin America Market Y-o-Y Growth (%) Projections by Product Type, 2023-2033
Figure 91: Latin America Market Value (US$ Mn) Analysis by Distribution Channels, 2017-2033
Figure 92: Latin America Market Value Share (%) and BPS Analysis by Distribution Channels, 2023-2033
Figure 93: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channels, 2023-2033
Figure 94: Latin America Market Value (US$ Mn) Analysis by Sector , 2017-2033
Figure 95: Latin America Market Value Share (%) and BPS Analysis by Sector , 2023-2033
Figure 96: Latin America Market Y-o-Y Growth (%) Projections by Sector , 2023-2033
Figure 97: Latin America Market Attractiveness by Product Type, 2023-2033
Figure 98: Latin America Market Attractiveness by Distribution Channels, 2023-2033
Figure 99: Latin America Market Attractiveness by Sector , 2023-2033
Figure 100: Latin America Market Attractiveness by Country, 2023-2033
Figure 101: Rest of the World Market Value (US$ Mn) by Product Type, 2023-2033
Figure 102: Rest of the World Market Value (US$ Mn) by Distribution Channels, 2023-2033
Figure 103: Rest of the World Market Value (US$ Mn) by Sector , 2023-2033
Figure 104: Rest of the World Market Value (US$ Mn) by Country, 2023-2033
Figure 105: Rest of the World Market Value (US$ Mn) Analysis by Country, 2017-2033
Figure 106: Rest of the World Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 107: Rest of the World Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 108: Rest of the World Market Value (US$ Mn) Analysis by Product Type, 2017-2033
Figure 109: Rest of the World Market Value Share (%) and BPS Analysis by Product Type, 2023-2033
Figure 110: Rest of the World Market Y-o-Y Growth (%) Projections by Product Type, 2023-2033
Figure 111: Rest of the World Market Value (US$ Mn) Analysis by Distribution Channels, 2017-2033
Figure 112: Rest of the World Market Value Share (%) and BPS Analysis by Distribution Channels, 2023-2033
Figure 113: Rest of the World Market Y-o-Y Growth (%) Projections by Distribution Channels, 2023-2033
Figure 114: Rest of the World Market Value (US$ Mn) Analysis by Sector , 2017-2033
Figure 115: Rest of the World Market Value Share (%) and BPS Analysis by Sector , 2023-2033
Figure 116: Rest of the World Market Y-o-Y Growth (%) Projections by Sector , 2023-2033
Figure 117: Rest of the World Market Attractiveness by Product Type, 2023-2033
Figure 118: Rest of the World Market Attractiveness by Distribution Channels, 2023-2033
Figure 119: Rest of the World Market Attractiveness by Sector , 2023-2033
Figure 120: Rest of the World Market Attractiveness by Country, 2023-2033
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
